Pharmacodynamic effects of standard dose prasugrel versus high dose clopidogrel in non-diabetic obese patients with coronary artery disease

Increased body weight is independently associated with impaired clopidogrel pharmacodynamic (PD) response. Prasugrel has more potent PD effects compared with clopidogrel, although its PD effects in obese patients are unknown. The aim of this prospective, randomised, study was to compare the PD effec...

Full description

Saved in:
Bibliographic Details
Published inThrombosis and haemostasis Vol. 111; no. 2; p. 258
Main Authors Darlington, Andrew, Tello-Montoliu, Antonio, Rollini, Fabiana, Ueno, Masafumi, Ferreiro, José Luis, Patel, Ronakkumar, Desai, Bhaloo, Guzman, Luis A, Bass, Theodore A, Angiolillo, Dominick J
Format Journal Article
LanguageEnglish
Published Germany 01.02.2014
Subjects
Online AccessGet more information

Cover

Loading…